Skip to main content
OpenTrials

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

1,388 public trials 159 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Completed

Study of Oral LOXO-338 in Patients With Advanced Blood Cancers

NCT05024045

Conditions
B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +29 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California San Francisco, Medical Center at Paranassus San Francisco, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
View all 23 locations
View Trial Details
Completed

ALICIA (Acalabrutinib in CLL Therapy)

NCT04746950

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Research Site Ufa, Bashkortostan Republic, Russia
  • Research Site Kaliningrad, Kaliningrad Oblast, Russia
  • Research Site Khabarovsk, Khabarovskiy Kray, Russia
  • Research Site Syktyvkar, Komi, Russia
View all 15 locations
View Trial Details
Completed

Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)

NCT04502030

Conditions
Agammaglobulinemia, Blood Protein Disorders, Chronic Disease, +18 more
Locations
  • Octapharma Research Site St. Petersburg, Florida, United States
  • Octapharma Research Site Columbus, Georgia, United States
  • Octapharma Research Site Macon, Georgia, United States
  • Octapharma Research Site New Orleans, Louisiana, United States
View all 84 locations
View Trial Details
Completed

ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies

NCT02362035

Conditions
Blood Protein Disorders, Burkitt Lymphoma, CLL, +47 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Los Angeles, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site Washington D.C., District of Columbia, United States
View all 19 locations
View Trial Details

Related conditions